Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Pembrolizumab +/− Lenvatinib for Head and Neck Cancer
Recruiting1 awardPhase 3
Fairfax, Virginia
This trial is studying whether giving pembrolizumab with or without lenvatinib to people with cancer of the head and neck who have PD-L1 selection is better than giving pembrolizumab with placebo.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.